HTG Molecular Diagnostics (HTG Molecular Diagnostics) Dividend Payout Ratio : 0.00 (As of Mar. 2023)

View and export this data going back to 2015. Start your Free Trial

What is HTG Molecular Diagnostics Dividend Payout Ratio?

HTG Molecular Diagnostics's dividend payout ratio for the months ended in Mar. 2023 was 0.00.

The historical rank and industry rank for HTG Molecular Diagnostics's Dividend Payout Ratio or its related term are showing as below:

HTGMQ's Dividend Payout Ratio is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-03), the Dividend Yield % of HTG Molecular Diagnostics is 0.00%.

HTG Molecular Diagnostics's Dividends per Share for the months ended in Mar. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

HTG Molecular Diagnostics Dividend Payout Ratio Historical Data

The historical data trend for HTG Molecular Diagnostics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Dividend Payout Ratio Chart

HTG Molecular Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividend Payout Ratio

Get a 7-Day Free Trial

HTG Molecular Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of HTG Molecular Diagnostics's Dividend Payout Ratio

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HTG Molecular Diagnostics's Dividend Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Dividend Payout Ratio falls into.

HTG Molecular Diagnostics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

HTG Molecular Diagnostics's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0	/	-24.28
	=	N/A

HTG Molecular Diagnostics's Dividend Payout Ratio for the quarter that ended in Mar. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2023 )	/	EPS without NRI (Q: Mar. 2023 )
	=	0	/	-2.28
	=	N/A

HTG Molecular Diagnostics (OTCPK:HTGMQ) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

HTG Molecular Diagnostics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

HTG Molecular Diagnostics (HTG Molecular Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (OTCPK:HTGMQ) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

3430 E. Global Loop, Tucson, AZ, USA, 85706

Website

https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

Executives

Stephen Barat	officer: Senior VP of Therapeutics	C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON AZ 85706
Thomas W. Dubensky	director	C/O ADURO BIOTECH, INC., 740 HEINZ AVENUE, BERKELEY CA 94710
L5 Capital Inc.	10 percent owner	1 FIRST CANADIAN PLACE, 39TH FLOOR, TORONTO A6 M5X 1H3
Christopher P Kiritsy	director
Byron Lawson	officer: SVP/Chief Commercial Officer	C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON AZ 85706
Tim B Johnson	director, officer: President & CEO
Laurence W Lytton	10 percent owner	467 CENTRAL PARK WEST, NY NY 10025
Laura Lee Godlewski	officer: VP of Accounting and Reporting	C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON AZ 85706
Michelle Renee Griffin	director	19723 NE 65TH LANE, KIRKLAND WA 98033
Shaun D Mcmeans	officer: VP, Finance & Admin. & CFO	3708 E COLUMBIA STREET, SUITE #110, TUCSON AZ 85714-3413
Novo Holdings A/s	10 percent owner	TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Plc Glaxosmithkline	10 percent owner	980 GREAT WEST ROAD, BRENTFORD MIDDLESEX X0 TW8 9GS
Nv Qiagen	10 percent owner	HULSTERWEG 82, PL VENLO P7 5912
Ann Hanham	director	ONE EMBRACADERO CTR, STE 2700, SAN FRANCISCO CA 94111
Don M Hardison	director